-
1
-
-
0037080547
-
This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors
-
American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias June 2001 and by the ERS Executive Committee, June 2001
-
American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002; 165 (2): 277-304.
-
(2002)
Am J Respir Crit Care Med
, vol.165
, Issue.2
, pp. 277-304
-
-
-
2
-
-
33749444308
-
Incidence and prevalence of idiopathic pulmonary fibrosis
-
DOI 10.1164/rccm.200602-163OC
-
Raghu G, Weycker D, Edelsberg J, et al. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006; 174 (7): 810-6. (Pubitemid 44511663)
-
(2006)
American Journal of Respiratory and Critical Care Medicine
, vol.174
, Issue.7
, pp. 810-816
-
-
Raghu, G.1
Weycker, D.2
Edelsberg, J.3
Bradford, W.Z.4
Oster, G.5
-
3
-
-
0029929285
-
Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation: A 10-year analysis of ANTADIR observatory
-
Chailleux E, Fauroux B, Binet F, et al. Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation: a 10-year analysis of ANTADIR Observatory. Chest 1996; 109 (3): 741-9. (Pubitemid 26086943)
-
(1996)
Chest
, vol.109
, Issue.3
, pp. 741-749
-
-
Chailleux, E.1
Fauroux, B.2
Binet, F.3
Dautzenberg, B.4
Polu, J.-M.5
-
4
-
-
17144401893
-
Evaluation of health-related quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests
-
DOI 10.1016/j.ejim.2004.09.013
-
Tzanakis N, Samiou M, Lambiri I, et al. Evaluation of healthrelated quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis: correlation with pulmonary function tests. Eur J Intern Med 2005; 16 (2): 105-12. (Pubitemid 40523053)
-
(2005)
European Journal of Internal Medicine
, vol.16
, Issue.2
, pp. 105-112
-
-
Tzanakis, N.1
Samiou, M.2
Lambiri, I.3
Antoniou, K.4
Siafakas, N.5
Bouros, D.6
-
5
-
-
0028072973
-
Oxygen improves maximal exercise performance in interstitial lung disease
-
Harris-Eze AO, Sridhar G, Clemens RE, et al. Oxygen improves maximal exercise performance in interstitial lung disease. Am J Respir Crit Care Med 1994; 150 (6 Pt 1): 1616-22. (Pubitemid 24361736)
-
(1994)
American Journal of Respiratory and Critical Care Medicine
, vol.150
, Issue.6 I
, pp. 1616-1622
-
-
Harris-Eze, A.O.1
Sridhar, G.2
Clemens, R.E.3
Gallagher, C.G.4
Marciniuk, D.D.5
-
7
-
-
0032433225
-
Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis
-
Tobin RW, Pope 2nd CE, Pellegrini CA, et al. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 158 (6): 1804-8. (Pubitemid 29008818)
-
(1998)
American Journal of Respiratory and Critical Care Medicine
, vol.158
, Issue.6
, pp. 1804-1808
-
-
Tobin, R.W.1
Pope II, C.E.2
Pellegrini, C.A.3
Emond, M.J.4
Sillery, J.5
Raghu, G.6
-
8
-
-
30744455313
-
High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis
-
DOI 10.1183/09031936.06.00037005
-
Raghu G, Freudenberger TD, Yang S, et al. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J 2006; 27 (1): 136-42. (Pubitemid 43092677)
-
(2006)
European Respiratory Journal
, vol.27
, Issue.1
, pp. 136-142
-
-
Raghu, G.1
Freudenberger, T.D.2
Yang, S.3
Curtis, J.R.4
Spada, C.5
Hayes, J.6
Sillery, J.K.7
Pope II, C.E.8
Pellegrini, C.A.9
-
9
-
-
33645124084
-
Sole treatment of acid gastroesophageal reflux in idiopathic pulmonary fibrosis: A case series
-
Raghu G, Yang ST, Spada C, et al. Sole treatment of acid gastroesophageal reflux in idiopathic pulmonary fibrosis: a case series. Chest 2006; 129 (3): 794-800.
-
(2006)
Chest
, vol.129
, Issue.3
, pp. 794-800
-
-
Raghu, G.1
Yang, S.T.2
Spada, C.3
-
10
-
-
70049102004
-
Obstructive sleep apnea is common in idiopathic pulmonary fibrosis
-
Lancaster LH, Mason WR, Parnell JA, et al. Obstructive sleep apnea is common in idiopathic pulmonary fibrosis. Chest 2009; 136 (3): 772-8.
-
(2009)
Chest
, vol.136
, Issue.3
, pp. 772-778
-
-
Lancaster, L.H.1
Mason, W.R.2
Parnell, J.A.3
-
11
-
-
57149114526
-
The association between idiopathic pulmonary fibrosis and vascular disease: A population-based study
-
Hubbard RB, Smith C, Le Jeune I, et al. The association between idiopathic pulmonary fibrosis and vascular disease: a population-based study. Am J Respir Crit Care Med 2008; 178 (12): 1257-61.
-
(2008)
Am J Respir Crit Care Med
, vol.178
, Issue.12
, pp. 1257-1261
-
-
Hubbard, R.B.1
Smith, C.2
Le Jeune, I.3
-
12
-
-
77952882026
-
Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis
-
Nathan SD, Basavaraj A, Reichner C, et al. Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis. Respir Med 2010; 104 (7): 1035-41.
-
(2010)
Respir Med
, vol.104
, Issue.7
, pp. 1035-1041
-
-
Nathan, S.D.1
Basavaraj, A.2
Reichner, C.3
-
13
-
-
33645118315
-
Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis
-
Lettieri CJ, Nathan SD, Barnett SD, et al. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006; 129 (3): 746-52.
-
(2006)
Chest
, vol.129
, Issue.3
, pp. 746-752
-
-
Lettieri, C.J.1
Nathan, S.D.2
Barnett, S.D.3
-
14
-
-
27144547143
-
Pulmonary hypertension in patients with idiopathic pulmonary fibrosis
-
DOI 10.1378/chest.128.4.2393
-
Nadrous HF, Pellikka PA, Krowka MJ, et al. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest 2005; 128 (4): 2393-9. (Pubitemid 41507585)
-
(2005)
Chest
, vol.128
, Issue.4
, pp. 2393-2399
-
-
Nadrous, H.F.1
Pellikka, P.A.2
Krowka, M.J.3
Swanson, K.L.4
Chaowalit, N.5
Decker, P.A.6
Ryu, J.H.7
-
15
-
-
0034011982
-
Idiopathic pulmonary fibrosis: Diagnosis and treatment. International consensus statement
-
American Thoracic Society American Thoracic Society (ATS), and the European Respiratory Society (ERS)
-
American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000; 161 (2 Pt 1): 646-64.
-
(2000)
Am J Respir Crit Care Med
, vol.161
, Issue.2 PART 1
, pp. 646-664
-
-
-
16
-
-
0345824715
-
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
-
DOI 10.1056/NEJMoa030511
-
Raghu G, Brown KK, Bradford WZ, et al. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 2004; 350 (2): 125-33. (Pubitemid 38056223)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.2
, pp. 125-133
-
-
Raghu, G.1
Brown, K.K.2
Bradford, W.Z.3
Starko, K.4
Noble, P.W.5
Schwartz, D.A.6
King Jr., T.E.7
-
17
-
-
20944434994
-
Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis
-
DOI 10.1164/rccm.200404-571OC
-
Azuma A, Nukiwa T, Tsuboi E, et al. Double-blind, placebo- controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2005; 171 (9): 1040-7. (Pubitemid 40616955)
-
(2005)
American Journal of Respiratory and Critical Care Medicine
, vol.171
, Issue.9
, pp. 1040-1047
-
-
Azuma, A.1
Nukiwa, T.2
Tsuboi, E.3
Suga, M.4
Abe, S.5
Nakata, K.6
Taguchi, Y.7
Nagai, S.8
Itoh, H.9
Ohi, M.10
Sato, A.11
Kudoh, S.12
Raghu, G.13
-
18
-
-
28144459814
-
High-dose acetylcysteine in idiopathic pulmonary fibrosis
-
DOI 10.1056/NEJMoa042976
-
DemedtsM, Behr J, Buhl R, et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis.NEngl JMed 2005; 353 (21): 2229-42. (Pubitemid 41697286)
-
(2005)
New England Journal of Medicine
, vol.353
, Issue.21
, pp. 2229-2242
-
-
Demedts, M.1
Behr, J.2
Buhl, R.3
Costabel, U.4
Dekhuijzen, R.5
Jansen, H.M.6
MacNee, W.7
Thomeer, M.8
Wallaert, B.9
Laurent, F.10
Nicholson, A.G.11
Verbeken, E.K.12
Verschakelen, J.13
Flower, C.D.R.14
Capron, F.15
Petruzzelli, S.16
De Vuyst, P.17
Van Den Bosch, J.M.M.18
Rodriguez-Becerra, E.19
Corvasce, G.20
Lankhorst, I.21
Sardina, M.22
Montanari, M.23
more..
-
19
-
-
24944467299
-
Anticoagulant therapy for idiopathic pulmonary fibrosis
-
DOI 10.1378/chest.128.3.1475
-
Kubo H, Nakayama K,YanaiM, et al.Anticoagulant therapy for idiopathic pulmonary fibrosis. Chest 2005; 128 (3): 1475-82. (Pubitemid 41324435)
-
(2005)
Chest
, vol.128
, Issue.3
, pp. 1475-1482
-
-
Kubo, H.1
Nakayama, K.2
Yanai, M.3
Suzuki, T.4
Yamaya, M.5
Watanabe, M.6
Sasaki, H.7
-
20
-
-
37849012578
-
BUILD-1: A randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis
-
King Jr TE, Behr J, Brown KK, et al. BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2008; 177 (1): 75-81.
-
(2008)
Am J Respir Crit Care Med
, vol.177
, Issue.1
, pp. 75-81
-
-
King Jr., T.E.1
Behr, J.2
Brown, K.K.3
-
21
-
-
55549147184
-
Treatment of idiopathic pulmonary fibrosis with etanercept: An exploratory, placebo-controlled trial
-
Raghu G, Brown KK, Costabel U, et al. Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial. Am J Respir Crit Care Med 2008; 178 (9): 948-55.
-
(2008)
Am J Respir Crit Care Med
, vol.178
, Issue.9
, pp. 948-955
-
-
Raghu, G.1
Brown, K.K.2
Costabel, U.3
-
22
-
-
67650349068
-
Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): A multicentre, randomised, placebo-controlled trial
-
King Jr TE, Albera C, Bradford WZ, et al. Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial. Lancet 2009; 374 (9685): 222-8.
-
(2009)
Lancet
, vol.374
, Issue.9685
, pp. 222-228
-
-
King Jr., T.E.1
Albera, C.2
Bradford, W.Z.3
-
23
-
-
77749324295
-
Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo- controlled trial results
-
Daniels CE, Lasky JA, Limper AH, et al. Imatinib treatment for idiopathic pulmonary fibrosis: randomized placebo- controlled trial results. Am J Respir Crit Care Med 2010; 181 (6): 604-10.
-
(2010)
Am J Respir Crit Care Med
, vol.181
, Issue.6
, pp. 604-610
-
-
Daniels, C.E.1
Lasky, J.A.2
Limper, A.H.3
-
24
-
-
79956341531
-
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): Two randomised trials
-
for the CAPACITY Study Group. Epub 2011 May 13
-
Noble PW, Albera C, Bradford WZ, et al., for the CAPACITY Study Group. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet. Epub 2011 May 13.
-
Lancet
-
-
Noble, P.W.1
Walbera, C.2
Bradford, W.Z.3
-
25
-
-
77951160564
-
Pirfenidone in idiopathic pulmonary fibrosis
-
Taniguchi H, Ebina M, Kondoh Y, et al. Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J 2010; 35 (4): 821-9.
-
(2010)
Eur Respir J
, vol.35
, Issue.4
, pp. 821-829
-
-
Taniguchi, H.1
Ebina, M.2
Kondoh, Y.3
-
26
-
-
77956640423
-
A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis
-
Zisman DA, Schwarz M, Anstrom KJ, et al. A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis. N Engl J Med 2010; 363 (7): 620-8.
-
(2010)
N Engl J Med
, vol.363
, Issue.7
, pp. 620-628
-
-
Zisman, D.A.1
Schwarz, M.2
Anstrom, K.J.3
-
27
-
-
20544443765
-
The clinical course of patients with idiopathic pulmonary fibrosis
-
Martinez FJ, Safrin S, Weycker D, et al. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med 2005; 142 (12 Pt 1): 963-7.
-
(2005)
Ann Intern Med
, vol.142
, Issue.12 PART 1
, pp. 963-967
-
-
Martinez, F.J.1
Safrin, S.2
Weycker, D.3
-
31
-
-
84857108790
-
-
Pulmonary-Allergy Drugs Advisory Committee [Accessed 2011 May 25]
-
Pulmonary-Allergy Drugs Advisory Committee. Pirfenidone NDA 22-535 [online]. Available from URL: http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/ UCM206399.pdf [Accessed 2011 May 25].
-
Pirfenidone NDA 22-535 [Online]
-
-
-
32
-
-
0025012363
-
What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust
-
Scott J, Johnston I, Britton J. What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust. BMJ 1990; 301 (6759): 1015-7. (Pubitemid 20381075)
-
(1990)
British Medical Journal
, vol.301
, Issue.6759
, pp. 1015-1017
-
-
Scott, J.1
Johnston, I.2
Britton, J.3
-
33
-
-
0030034711
-
Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis
-
DOI 10.1016/S0140-6736(96)90465-1
-
Hubbard R, Lewis S, Richards K, et al. Occupational exposure tometal or wood dust and aetiology of cryptogenic fibrosing alveolitis. Lancet 1996; 347 (8997): 284-9. (Pubitemid 26041039)
-
(1996)
Lancet
, vol.347
, Issue.8997
, pp. 284-289
-
-
Hubbard, R.1
Lewis, S.2
Richards, K.3
Johnston, I.4
Britton, J.5
-
34
-
-
0027977910
-
Idiopathic pulmonary fibrosis: Epidemiologic approaches to occupational exposure
-
Iwai K, Mori T, Yamada N, et al. Idiopathic pulmonary fibrosis: epidemiologic approaches to occupational exposure. Am J Respir Crit Care Med 1994; 150 (3): 670-5. (Pubitemid 24291493)
-
(1994)
American Journal of Respiratory and Critical Care Medicine
, vol.150
, Issue.3
, pp. 670-675
-
-
Iwai, K.1
Mori, T.2
Yamada, N.3
Yamaguchi, M.4
Hosoda, Y.5
-
35
-
-
0034663835
-
Occupational and environmental risk factors for idiopathic pulmonary fibrosis: A multicenter case-control study
-
DOI 10.1093/aje/152.4.307
-
Baumgartner KB, Samet JM, Coultas DB, et al. Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study. Am J Epidemiol 2000; 152 (4): 307-15. (Pubitemid 30626724)
-
(2000)
American Journal of Epidemiology
, vol.152
, Issue.4
, pp. 307-315
-
-
Baumgartner, K.B.1
Samet, J.M.2
Coultas, D.B.3
Stidley, C.A.4
Hunt, W.C.5
Colby, T.V.6
Waldron, J.A.7
Baughman, R.8
Davis, G.S.9
Garcia, J.G.N.10
Hunningshake, G.W.11
Kallay, M.C.12
King Jr., T.E.13
Krowka, M.J.14
Rennard, S.I.15
Ryu, J.H.16
Sherman, C.B.17
Smith, L.J.18
Toews, G.19
Winterbauer, R.H.20
more..
-
36
-
-
20244387445
-
Occupational and environmental factors and idiopathic pulmonary fibrosis in Japan
-
DOI 10.1093/annhyg/meh090
-
Miyake Y, Sasaki S, Yokoyama T, et al. Occupational and environmental factors and idiopathic pulmonary fibrosis in Japan. Ann Occup Hyg 2005; 49 (3): 259-65. (Pubitemid 40547331)
-
(2005)
Annals of Occupational Hygiene
, vol.49
, Issue.3
, pp. 259-265
-
-
Miyake, Y.1
Sasaki, S.2
Yokoyama, T.3
Chida, K.4
Azuma, A.5
Suda, T.6
Kudoh, S.7
Sakamoto, N.8
Okamoto, K.9
Kobashi, G.10
Washio, M.11
Inaba, Y.12
Tanaka, H.13
-
37
-
-
43449105048
-
Occupational risks for idiopathic pulmonary fibrosis mortality in the United States
-
PinheiroGA, Antao VC,Wood JM, et al. Occupational risks for idiopathic pulmonary fibrosis mortality in the United States. Int J Occup Environ Health 2008; 14 (2): 117-23. (Pubitemid 351671416)
-
(2008)
International Journal of Occupational and Environmental Health
, vol.14
, Issue.2
, pp. 117-123
-
-
Pinheiro, G.A.1
Antao, V.C.2
Wood, J.M.3
Wassell, J.T.4
-
38
-
-
34548219031
-
Occupational exposure and severe pulmonary fibrosis
-
DOI 10.1016/j.rmed.2007.02.027, PII S095461110700220X
-
Gustafson T, Dahlman-Hoglund A, Nilsson K, et al. Occupational exposure and severe pulmonary fibrosis. Respir Med 2007; 101 (10): 2207-12. (Pubitemid 47324247)
-
(2007)
Respiratory Medicine
, vol.101
, Issue.10
, pp. 2207-2212
-
-
Gustafson, T.1
Dahlman-Hoglund, A.2
Nilsson, K.3
Strom, K.4
Tornling, G.5
Toren, K.6
-
39
-
-
0031893420
-
Case-control study of idiopathic pulmonary fibrosis and environmental exposures
-
DOI 10.1097/00043764-199804000-00011
-
Mullen J, Hodgson MJ, DeGraff CA, et al. Case-control study of idiopathic pulmonary fibrosis and environmental exposures. J Occup Environ Med 1998; 40 (4): 363-7. (Pubitemid 28180813)
-
(1998)
Journal of Occupational and Environmental Medicine
, vol.40
, Issue.4
, pp. 363-367
-
-
Mullen, J.1
Hodgson, M.J.2
DeGraff, C.A.3
Godar, T.4
-
40
-
-
34547418228
-
Inhalation of inorganic particles as a risk factor for idiopathic pulmonary fibrosis-Elemental microanalysis of pulmonary lymph nodes obtained at autopsy cases
-
DOI 10.1016/j.prp.2007.04.008, PII S0344033807000891
-
Kitamura H, Ichinose S, Hosoya T, et al. Inhalation of inorganic particles as a risk factor for idiopathic pulmonary fibrosis: elemental microanalysis of pulmonary lymph nodes obtained at autopsy cases. Pathol Res Pract 2007; 203 (8): 575-85. (Pubitemid 47163498)
-
(2007)
Pathology Research and Practice
, vol.203
, Issue.8
, pp. 575-585
-
-
Kitamura, H.1
Ichinose, S.2
Hosoya, T.3
Ando, T.4
Ikushima, S.5
Oritsu, M.6
Takemura, T.7
-
41
-
-
0037790724
-
Diabetes mellitus may increase risk for idiopathic pulmonary fibrosis
-
DOI 10.1378/chest.123.6.2007
-
Enomoto T, Usuki J, Azuma A, et al. Diabetes mellitus may increase risk for idiopathic pulmonary fibrosis. Chest 2003; 123 (6): 2007-11. (Pubitemid 36706726)
-
(2003)
Chest
, vol.123
, Issue.6
, pp. 2007-2011
-
-
Enomoto, T.1
Usuki, J.2
Azuma, A.3
Nakagawa, T.4
Kudoh, S.5
-
42
-
-
30344471883
-
Clinical and pathologic features of familial interstitial pneumonia
-
DOI 10.1164/rccm.200408-1104OC
-
Steele MP, Speer MC, Loyd JE, et al. Clinical and pathologic features of familial interstitial pneumonia. Am J Respir Crit Care Med 2005; 172 (9): 1146-52. (Pubitemid 43066651)
-
(2005)
American Journal of Respiratory and Critical Care Medicine
, vol.172
, Issue.9
, pp. 1146-1152
-
-
Steele, M.P.1
Speer, M.C.2
Loyd, J.E.3
Brown, K.K.4
Herron, A.5
Slifer, S.H.6
Burch, L.H.7
Wahidi, M.M.8
Phillips III, J.A.9
Sporn, T.A.10
McAdams, H.P.11
Schwarz, M.I.12
Schwartz, D.A.13
-
43
-
-
33744908816
-
Is idiopathic pulmonary fibrosis an environmental disease?
-
DOI 10.1513/pats.200512-131TK
-
Taskar VS, Coultas DB. Is idiopathic pulmonary fibrosis an environmental disease? Proc Am Thorac Soc 2006; 3 (4): 293-8. (Pubitemid 43845405)
-
(2006)
Proceedings of the American Thoracic Society
, vol.3
, Issue.4
, pp. 293-298
-
-
Taskar, V.S.1
Coultas, D.B.2
-
44
-
-
73749083315
-
Risk factors for idiopathic pulmonary fibrosis in a Mexican population: A case-control study
-
Garcia-Sancho Figueroa MC, Carrillo G, Perez-Padilla R, et al. Risk factors for idiopathic pulmonary fibrosis in a Mexican population: a case-control study. Respir Med 2010; 104 (2): 305-9.
-
(2010)
Respir Med
, vol.104
, Issue.2
, pp. 305-309
-
-
Garcia-Sancho Figueroa, M.C.1
Carrillo, G.2
Perez-Padilla, R.3
-
45
-
-
38349039634
-
Idiopathic pulmonary fibrosis: Outcome in relation to smoking status
-
Antoniou KM, Hansell DM, Rubens MB, et al. Idiopathic pulmonary fibrosis: outcome in relation to smoking status. Am J Respir Crit Care Med 2008; 177 (2): 190-4.
-
(2008)
Am J Respir Crit Care Med
, vol.177
, Issue.2
, pp. 190-194
-
-
Antoniou, K.M.1
Hansell, D.M.2
Rubens, M.B.3
-
46
-
-
0035482002
-
Predicting survival in idiopathic pulmonary fibrosis: Scoring system and survival model
-
King Jr TE, Tooze JA, Schwarz MI, et al. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001; 164 (7): 1171-81. (Pubitemid 33052246)
-
(2001)
American Journal of Respiratory and Critical Care Medicine
, vol.164
, Issue.7
, pp. 1171-1181
-
-
King Jr., T.E.1
Tooze, J.A.2
Schwarz, M.I.3
Brown, K.R.4
Cherniack, R.M.5
-
47
-
-
33947193484
-
Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation
-
DOI 10.1016/j.jtcvs.2006.09.085, PII S0022522306021222
-
Sweet MP, Patti MG, Leard LE, et al. Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation. J Thorac Cardiovasc Surg 2007; 133 (4): 1078-84. (Pubitemid 46435907)
-
(2007)
Journal of Thoracic and Cardiovascular Surgery
, vol.133
, Issue.4
, pp. 1078-1084
-
-
Sweet, M.P.1
Patti, M.G.2
Leard, L.E.3
Golden, J.A.4
Hays, S.R.5
Hoopes, C.6
Theodore, P.R.7
-
48
-
-
67349242705
-
Role of diabetes mellitus and gastro-oesophageal reflux in the aetiology of idiopathic pulmonary fibrosis
-
Gribbin J, Hubbard R, Smith C. Role of diabetes mellitus and gastro-oesophageal reflux in the aetiology of idiopathic pulmonary fibrosis. Respir Med 2009; 103 (6): 927-31.
-
(2009)
Respir Med
, vol.103
, Issue.6
, pp. 927-931
-
-
Gribbin, J.1
Hubbard, R.2
Smith, C.3
-
49
-
-
63349106611
-
Gastroesophageal reflux and pulmonary fibrosis in scleroderma: A study using pH-impedance monitoring
-
Savarino E, Bazzica M, Zentilin P, et al. Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. Am J Respir Crit Care Med 2009; 179 (5): 408-13.
-
(2009)
Am J Respir Crit Care Med
, vol.179
, Issue.5
, pp. 408-413
-
-
Savarino, E.1
Bazzica, M.2
Zentilin, P.3
-
50
-
-
25144492092
-
Prevalence of gastroesophageal reflux in end-stage lung disease candidates for lung transplant
-
DOI 10.1016/j.athoracsur.2005.03.106, PII S0003497505005667
-
D'Ovidio F, Singer LG, Hadjiliadis D, et al. Prevalence of gastroesophageal reflux in end-stage lung disease candidates for lung transplant. Ann Thorac Surg 2005; 80 (4): 1254-60. (Pubitemid 41354098)
-
(2005)
Annals of Thoracic Surgery
, vol.80
, Issue.4
, pp. 1254-1260
-
-
D'Ovidio, F.1
Singer, L.G.2
Hadjiliadis, D.3
Pierre, A.4
Waddell, T.K.5
De Perrot, M.6
Hutcheon, M.7
Miller, L.8
Darling, G.9
Keshavjee, S.10
-
51
-
-
56449105355
-
Prevalence of gastroesophageal reflux in lung transplant candidates with advanced lung disease
-
FortunatoGA, Machado MM, Andrade CF, et al. Prevalence of gastroesophageal reflux in lung transplant candidates with advanced lung disease. J Bras Pneumol 2008; 34 (10): 772-8.
-
(2008)
J Bras Pneumol
, vol.34
, Issue.10
, pp. 772-778
-
-
Fortunato, G.A.1
MacHado, M.M.2
Andrade, C.F.3
-
52
-
-
0031947005
-
Immunohistochemical localisation of advanced glycation end products in pulmonary fibrosis
-
Matsuse T, Ohga E, Teramoto S, et al. Immunohistochemical localisation of advanced glycation end products in pulmonary fibrosis. J Clin Pathol 1998; 51 (7): 515-9. (Pubitemid 28375031)
-
(1998)
Journal of Clinical Pathology
, vol.51
, Issue.7
, pp. 515-519
-
-
Matsuse, T.1
Ohga, E.2
Teramoto, S.3
Fukayama, M.4
Nagai, R.5
Horiuchi, S.6
Ouchi, Y.7
-
53
-
-
70249113403
-
Blockade of advanced glycation end product formation attenuates bleomycininduced pulmonary fibrosis in rats
-
Chen L, Wang T, Wang X, et al. Blockade of advanced glycation end product formation attenuates bleomycininduced pulmonary fibrosis in rats. Respir Res 2009; 10: 55.
-
(2009)
Respir Res
, vol.10
, pp. 55
-
-
Chen, L.1
Wang, T.2
Wang, X.3
-
54
-
-
40449092262
-
A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis
-
DOI 10.2353/ajpath.2008.070569
-
Englert JM, Hanford LE, Kaminski N, et al. A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis. Am J Pathol 2008; 172 (3): 583-91. (Pubitemid 351354532)
-
(2008)
American Journal of Pathology
, vol.172
, Issue.3
, pp. 583-591
-
-
Englert, J.M.1
Hanford, L.E.2
Kaminski, N.3
Tobolewski, J.M.4
Tan, R.J.5
Fattman, C.L.6
Ramsgaard, L.7
Richards, T.J.8
Loutaev, I.9
Nawroth, P.P.10
Kasper, M.11
Bierhaus, A.12
Oury, T.D.13
-
55
-
-
51249114838
-
Loss of RAGE in pulmonary fibrosis: Molecular relations to functional changes in pulmonary cell types
-
Queisser MA, Kouri FM, Konigshoff M, et al. Loss of RAGE in pulmonary fibrosis: molecular relations to functional changes in pulmonary cell types. Am J Respir Cell Mol Biol 2008; 39 (3): 337-45.
-
(2008)
Am J Respir Cell Mol Biol
, vol.39
, Issue.3
, pp. 337-345
-
-
Queisser, M.A.1
Kouri, F.M.2
Konigshoff, M.3
-
56
-
-
0037102396
-
A rearranged form of Epstein-Barr virus DNA is associated with idiopathic pulmonary fibrosis
-
Kelly BG, Lok SS, Hasleton PS, et al. A rearranged form of Epstein-Barr virus DNA is associated with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002; 166 (4): 510-3.
-
(2002)
Am J Respir Crit Care Med
, vol.166
, Issue.4
, pp. 510-513
-
-
Kelly, B.G.1
Lok, S.S.2
Hasleton, P.S.3
-
57
-
-
0034752512
-
Epstein-Barr virus and wild p53 in idiopathic pulmonary fibrosis
-
DOI 10.1053/rmed.2001.1152
-
Lok SS, Stewart JP, Kelly BG, et al. Epstein-Barr virus and wild p53 in idiopathic pulmonary fibrosis. Respir Med 2001; 95 (10): 787-91. (Pubitemid 33019572)
-
(2001)
Respiratory Medicine
, vol.95
, Issue.10
, pp. 787-791
-
-
Lok, S.S.1
Stewart, J.P.2
Kelly, B.G.3
Hasleton, P.S.4
Egan, J.J.5
-
58
-
-
0032958746
-
The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis
-
Stewart JP, Egan JJ, Ross AJ, et al. The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1999; 159 (4 Pt 1): 1336-41. (Pubitemid 29202576)
-
(1999)
American Journal of Respiratory and Critical Care Medicine
, vol.159
, Issue.4 I
, pp. 1336-1341
-
-
Stewart, J.P.1
Egan, J.J.2
Ross, A.J.3
Kelly, B.G.4
Lok, S.S.5
Hasleton, P.S.6
Woodcock, A.A.7
-
59
-
-
0038519288
-
Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis
-
Tang YW, Johnson JE, Browning PJ, et al. Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis. J Clin Microbiol 2003; 41 (6): 2633-40. (Pubitemid 36712478)
-
(2003)
Journal of Clinical Microbiology
, vol.41
, Issue.6
, pp. 2633-2640
-
-
Tang, Y.-W.1
Johnson, J.E.2
Browning, P.J.3
Cruz-Gervis, R.A.4
Davis, A.5
Graham, B.S.6
Brigham, K.L.7
Oates Jr., J.A.8
Loyd, J.E.9
Stecenko, A.A.10
-
60
-
-
48949119341
-
Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: Association with altered surfactant protein processing and herpesvirus infection
-
Lawson WE, Crossno PF, Polosukhin VV, et al. Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection. Am J Physiol Lung Cell Mol Physiol 2008; 294 (6): L1119-26.
-
(2008)
Am J Physiol Lung Cell Mol Physiol
, vol.294
, Issue.6
-
-
Lawson, W.E.1
Crossno, P.F.2
Polosukhin, V.V.3
-
61
-
-
0037373514
-
Lack of evidence for a role of Epstein-Barr virus in the increase of lung cancer in idiopathic pulmonary fibrosis
-
DOI 10.1053/rmed.2003.1398
-
Hayakawa H, Shirai M, Uchiyama H, et al. Lack of evidence for a role of Epstein-Barr virus in the increase of lung cancer in idiopathic pulmonary fibrosis. Respir Med 2003; 97 (3): 281-4. (Pubitemid 36266885)
-
(2003)
Respiratory Medicine
, vol.97
, Issue.3
, pp. 281-284
-
-
Hayakawa, H.1
Shirai, M.2
Uchiyama, H.3
Imokawa, S.4
Suda, T.5
Chida, K.6
Muro, H.7
-
62
-
-
22544487197
-
HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosis
-
Zamo A, Poletti V, Reghellin D, et al. HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22 (2): 123-8. (Pubitemid 41020017)
-
(2005)
Sarcoidosis Vasculitis and Diffuse Lung Diseases
, vol.22
, Issue.2
, pp. 123-128
-
-
Zamo, A.1
Poletti, V.2
Reghellin, D.3
Montagna, L.4
Pedron, S.5
Piccoli, P.6
Chilosi, M.7
-
63
-
-
27144534791
-
Lung infection with γ-herpesvirus induces progressive pulmonary fibrosis in Th2-biased mice
-
DOI 10.1152/ajplung.00007.2005
-
Mora AL, Woods CR, Garcia A, et al. Lung infection with gamma-herpesvirus induces progressive pulmonary fibrosis in Th2-biased mice. Am J Physiol Lung Cell Mol Physiol 2005; 289 (5): L711-21. (Pubitemid 41504401)
-
(2005)
American Journal of Physiology - Lung Cellular and Molecular Physiology
, vol.289
, Issue.5
-
-
Mora, A.L.1
Woods, C.R.2
Garcia, A.3
Xu, J.4
Rojas, M.5
Speck, S.H.6
Roman, J.7
Brigham, K.L.8
Stecenko, A.A.9
-
64
-
-
41749097019
-
Exacerbation of established pulmonary fibrosis in a murine model by gammaherpesvirus
-
DOI 10.1164/rccm.200708-1184OC
-
McMillan TR, Moore BB, Weinberg JB, et al. Exacerbation of established pulmonary fibrosis in a murine model by gammaherpesvirus. Am J Respir Crit Care Med 2008; 177 (7): 771-80. (Pubitemid 351490564)
-
(2008)
American Journal of Respiratory and Critical Care Medicine
, vol.177
, Issue.7
, pp. 771-780
-
-
McMillan, T.R.1
Moore, B.B.2
Weinberg, J.B.3
Vannella, K.M.4
Fields, W.B.5
Christensen, P.J.6
Van Dyk, L.F.7
Toews, G.B.8
-
65
-
-
0021077452
-
Mechanisms of pulmonary fibrosis. Spontaneous release of the alveolar macrophage-derived growth factor in the interstitial lung disorder
-
Bitterman PB, Adelberg S, Crystal RG. Mechanisms of pulmonary fibrosis: spontaneous release of the alveolar macrophage-derived growth factor in the interstitial lung disorders. J Clin Invest 1983; 72 (5): 1801-13. (Pubitemid 14229060)
-
(1983)
Journal of Clinical Investigation
, vol.72
, Issue.5
, pp. 1801-1813
-
-
Bitterman, P.B.1
Adelberg, S.2
Crystal, R.G.3
-
66
-
-
0035895243
-
Idiopathic pulmonary fibrosis: Prevailing and evolving hypotheses about its pathogenesis and implications for therapy
-
SelmanM,King TE, PardoA. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann InternMed 2001; 134 (2): 136-51. (Pubitemid 32096342)
-
(2001)
Annals of Internal Medicine
, vol.134
, Issue.2
, pp. 136-151
-
-
Selman, M.1
King Jr., T.E.2
Pardo, A.3
-
67
-
-
0042171695
-
A clinical study of idiopathic pulmonary fibrosis based on autopsy studies in elderly patients
-
Araki T, Katsura H, Sawabe M, et al. A clinical study of idiopathic pulmonary fibrosis based on autopsy studies in elderly patients. Intern Med 2003; 42 (6): 483-9. (Pubitemid 36926809)
-
(2003)
Internal Medicine
, vol.42
, Issue.6
, pp. 483-489
-
-
Araki, T.1
Katsura, H.2
Sawabe, M.3
Kida, K.4
-
68
-
-
71149086939
-
Short telomeres are sufficient to cause the degenerative defects associated with aging
-
Armanios M, Alder JK, Parry EM, et al. Short telomeres are sufficient to cause the degenerative defects associated with aging. Am J Hum Genet 2009; 85 (6): 823-32.
-
(2009)
Am J Hum Genet
, vol.85
, Issue.6
, pp. 823-832
-
-
Armanios, M.1
Alder, J.K.2
Parry, E.M.3
-
69
-
-
34548667973
-
Telomere length, stem cells and aging
-
DOI 10.1038/nchembio.2007.38, PII NCHEMBIO200738
-
Blasco MA. Telomere length, stem cells and aging. Nat Chem Biol 2007; 3 (10): 640-9. (Pubitemid 47417712)
-
(2007)
Nature Chemical Biology
, vol.3
, Issue.10
, pp. 640-649
-
-
Blasco, M.A.1
-
70
-
-
34250614359
-
Adult-onset pulmonary fibrosis caused by mutations in telomerase
-
DOI 10.1073/pnas.0701009104
-
Tsakiri KD, Cronkhite JT, Kuan PJ, et al. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc Natl Acad Sci USA 2007; 104 (18): 7552-7. (Pubitemid 47185944)
-
(2007)
Proceedings of the National Academy of Sciences of the United States of America
, vol.104
, Issue.18
, pp. 7552-7557
-
-
Tsakiri, K.D.1
Cronkhite, J.T.2
Kuan, P.J.3
Xing, C.4
Raghu, G.5
Weissler, J.C.6
Rosenblatt, R.L.7
Shay, J.W.8
Garcia, C.K.9
-
71
-
-
51349113450
-
Short telomeres are a risk factor for idiopathic pulmonary fibrosis
-
Alder JK, Chen JJ, Lancaster L, et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci USA 2008; 105 (35): 13051-6.
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, Issue.35
, pp. 13051-6
-
-
Alder, J.K.1
Chen, J.J.2
Lancaster, L.3
-
72
-
-
52749083873
-
Telomere shortening in familial and sporadic pulmonary fibrosis
-
Cronkhite JT, Xing C, RaghuG, et al. Telomere shortening in familial and sporadic pulmonary fibrosis. Am J Respir Crit Care Med 2008; 178 (7): 729-37.
-
(2008)
Am J Respir Crit Care Med
, vol.178
, Issue.7
, pp. 729-737
-
-
Cronkhite, J.T.1
Xing, C.2
Raghu, G.3
-
73
-
-
52749089332
-
Idiopathic pulmonary fibrosis: A disorder of lung regeneration?
-
Thannickal VJ, Loyd JE. Idiopathic pulmonary fibrosis: a disorder of lung regeneration?Am J Respir Crit Care Med 2008; 178 (7): 663-5.
-
(2008)
Am J Respir Crit Care Med
, vol.178
, Issue.7
, pp. 663-665
-
-
Thannickal, V.J.1
Loyd, J.E.2
-
74
-
-
0021705255
-
Chronic cigarette smoke inhalation and aging in mice: 1. Morphologic and functional lung abnormalities
-
Matulionis DH. Chronic cigarette smoke inhalation and aging in mice: 1, morphologic and functional lung abnormalities. Exp Lung Res 1984; 7 (3-4): 237-56. (Pubitemid 15173751)
-
(1984)
Experimental Lung Research
, vol.7
, Issue.3-4
, pp. 237-256
-
-
Matulionis, D.H.1
-
75
-
-
23644461803
-
Oxidative stress in pulmonary fibrosis: A possible role for redox modulatory therapy
-
DOI 10.1164/rccm.200501-017PP
-
Kinnula VL, Fattman CL, Tan RJ, et al. Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy. Am J Respir Crit Care Med 2005; 172 (4): 417-22. (Pubitemid 41117386)
-
(2005)
American Journal of Respiratory and Critical Care Medicine
, vol.172
, Issue.4
, pp. 417-422
-
-
Kinnula, V.L.1
Fattman, C.L.2
Tan, R.J.3
Oury, T.D.4
-
76
-
-
73449140168
-
Molecular pathogenesis of liver fibrosis
-
Brenner DA. Molecular pathogenesis of liver fibrosis. Trans Am Clin Climatol Assoc 2009; 120: 361-8.
-
(2009)
Trans Am Clin Climatol Assoc
, vol.120
, pp. 361-368
-
-
Brenner, D.A.1
-
77
-
-
0030215822
-
P21(Waf1/Cip1/Sdi1) and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis
-
Kuwano K, Kunitake R, Kawasaki M, et al. P21Waf1/ Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1996; 154 (2 Pt 1): 477-83. (Pubitemid 26269122)
-
(1996)
American Journal of Respiratory and Critical Care Medicine
, vol.154
, Issue.2
, pp. 477-483
-
-
Kuwano, K.1
Kunitake, R.2
Kawasaki, M.3
Nomoto, Y.4
Hagimoto, N.5
Nakanishi, Y.6
Hara, N.7
-
78
-
-
0031761169
-
8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases
-
Montuschi P, Ciabattoni G, Paredi P, et al. 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases. Am J Respir Crit Care Med 1998; 158 (5 Pt 1): 1524-7.
-
(1998)
Am J Respir Crit Care Med
, vol.158
, Issue.5 PART 1
, pp. 1524-1527
-
-
Montuschi, P.1
Ciabattoni, G.2
Paredi, P.3
-
79
-
-
12244286790
-
Oxidative stress in lung epithelial cells from patients with idiopathic interstitial pneumonias
-
DOI 10.1183/09031936.03.00063203
-
Kuwano K, Nakashima N, Inoshima I, et al. Oxidative stress in lung epithelial cells from patients with idiopathic interstitial pneumonias. Eur Respir J 2003; 21 (2): 232-40. (Pubitemid 36204536)
-
(2003)
European Respiratory Journal
, vol.21
, Issue.2
, pp. 232-240
-
-
Kuwano, K.1
Nakashima, N.2
Inoshima, I.3
Hagimoto, N.4
Fujita, M.5
Yoshimi, M.6
Maeyama, T.7
Hamada, N.8
Watanabe, K.9
Hara, N.10
-
80
-
-
34347257042
-
Nox enzymes, ROS, and chronic disease: An example of antagonistic pleiotropy
-
DOI 10.1016/j.freeradbiomed.2007.03.027, PII S0891584907002225
-
Lambeth JD. Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy. Free Radic Biol Med 2007; 43 (3): 332-47. (Pubitemid 46992767)
-
(2007)
Free Radical Biology and Medicine
, vol.43
, Issue.3
, pp. 332-347
-
-
Lambeth, J.D.1
-
81
-
-
33845345975
-
Oxidative stress induces premature senescence by stimulating caveolin-1 gene transcription through p38 mitogen-activated protein kinase/Sp1-mediated activation of two GC-rich promoter elements
-
DOI 10.1158/0008-5472.CAN-06-1236
-
Dasari A, Bartholomew JN, Volonte D, et al. Oxidative stress induces premature senescence by stimulating caveolin-1 gene transcription through p38 mitogenactivated protein kinase/Sp1-mediated activation of two GC-rich promoter elements. Cancer Res 2006; 66 (22): 10805-14. (Pubitemid 44876976)
-
(2006)
Cancer Research
, vol.66
, Issue.22
, pp. 10805-10814
-
-
Dasari, A.1
Bartholomew, J.N.2
Volonte, D.3
Galbiati, F.4
-
82
-
-
70349129549
-
Accelerated lung aging: A novel pathogenic mechanism of chronic obstructive pulmonary disease (COPD)
-
MacNee W. Accelerated lung aging: a novel pathogenic mechanism of chronic obstructive pulmonary disease (COPD). Biochem Soc Trans 2009; 37 (Pt 4): 819-23.
-
(2009)
Biochem Soc Trans
, vol.37
, Issue.PART 4
, pp. 819-823
-
-
MacNee, W.1
-
83
-
-
0029023626
-
Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved
-
Wang E. Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved. Cancer Res 1995; 55 (11): 2284-92.
-
(1995)
Cancer Res
, vol.55
, Issue.11
, pp. 2284-2292
-
-
Wang, E.1
-
84
-
-
34548186667
-
Cellular senescence: When bad things happen to good cells
-
DOI 10.1038/nrm2233, PII NRM2233
-
Campisi J, d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007; 8 (9): 729-40. (Pubitemid 47312822)
-
(2007)
Nature Reviews Molecular Cell Biology
, vol.8
, Issue.9
, pp. 729-740
-
-
Campisi, J.1
D'Adda Di Fagagna, F.2
-
85
-
-
0033732110
-
Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes
-
Toussaint O, Medrano EE, von Zglinicki T. Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes. Exp Gerontol 2000; 35 (8): 927-45.
-
(2000)
Exp Gerontol
, vol.35
, Issue.8
, pp. 927-945
-
-
Toussaint, O.1
Medrano, E.E.2
Von Zglinicki, T.3
-
86
-
-
18144371956
-
Hydrogen peroxide is a diffusible paracrine signal for the induction of epithelial cell death by activated myofibroblasts
-
DOI 10.1096/fj.04-2882fje
-
Waghray M, Cui Z, Horowitz JC, et al. Hydrogen peroxide is a diffusible paracrine signal for the induction of epithelial cell death by activated myofibroblasts. FASEB J 2005; 19 (7): 854-6. (Pubitemid 40617407)
-
(2005)
FASEB Journal
, vol.19
, Issue.7
, pp. 854-856
-
-
Waghray, M.1
Cui, Z.2
Horowitz, J.C.3
Subramanian, I.M.4
Martinez, F.J.5
Toews, G.B.6
Thannickal, V.J.7
-
87
-
-
0035907349
-
Oxidative protein cross-linking reactions involving L-tyrosine in transforming growth factor-beta1-stimulated fibroblasts
-
Larios JM, Budhiraja R, Fanburg BL, et al. Oxidative protein cross-linking reactions involving L-tyrosine in transforming growth factor-beta1-stimulated fibroblasts. J Biol Chem 2001; 276 (20): 17437-41.
-
(2001)
J Biol Chem
, vol.276
, Issue.20
, pp. 17437-41
-
-
Larios, J.M.1
Budhiraja, R.2
Fanburg, B.L.3
-
88
-
-
26444442450
-
Endoplasmic reticulum stress: Cell life and death decisions
-
DOI 10.1172/JCI26373
-
Xu C, Bailly-Maitre B, Reed JC. Endoplasmic reticulum stress: cell life and death decisions. JClin Invest 2005; 115 (10): 2656-64. (Pubitemid 41434389)
-
(2005)
Journal of Clinical Investigation
, vol.115
, Issue.10
, pp. 2656-2664
-
-
Xu, C.1
Bailly-Maitre, B.2
Reed, J.C.3
-
89
-
-
54049115076
-
Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis
-
Korfei M, Ruppert C, Mahavadi P, et al. Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2008; 178 (8): 838-46.
-
(2008)
Am J Respir Crit Care Med
, vol.178
, Issue.8
, pp. 838-846
-
-
Korfei, M.1
Ruppert, C.2
Mahavadi, P.3
-
91
-
-
17844384822
-
Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-β1: Potential role in idiopathic pulmonary fibrosis
-
Willis BC, Liebler JM, Luby-Phelps K, et al. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am J Pathol 2005; 166 (5): 1321-32. (Pubitemid 40586504)
-
(2005)
American Journal of Pathology
, vol.166
, Issue.5
, pp. 1321-1332
-
-
Willis, B.C.1
Liebler, J.M.2
Luby-Phelps, K.3
Nicholson, A.G.4
Crandall, E.D.5
Du Bois, R.M.6
Borok, Z.7
-
92
-
-
33748375828
-
Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix
-
DOI 10.1073/pnas.0605669103
-
Kim KK, Kugler MC, Wolters PJ, et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA 2006; 103 (35): 13180-5. (Pubitemid 44338936)
-
(2006)
Proceedings of the National Academy of Sciences of the United States of America
, vol.103
, Issue.35
, pp. 13180-13185
-
-
Kim, K.K.1
Kugler, M.C.2
Wolters, P.J.3
Robillard, L.4
Galvez, M.G.5
Brumwell, A.M.6
Sheppard, D.7
Chapman, H.A.8
-
93
-
-
70349441112
-
Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis
-
Tanjore H, Xu XC, Polosukhin VV, et al. Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis. Am J Respir Crit Care Med 2009; 180 (7): 657-65.
-
(2009)
Am J Respir Crit Care Med
, vol.180
, Issue.7
, pp. 657-665
-
-
Tanjore, H.1
Xu, X.C.2
Polosukhin, V.V.3
-
94
-
-
0242500879
-
Aberrant Wnt/β-catenin pathway activation in idiopathic pulmonary fibrosis
-
Chilosi M, Poletti V, Zamo A, et al. Aberrant Wnt/betacatenin pathway activation in idiopathic pulmonary fibrosis. Am J Pathol 2003; 162 (5): 1495-502. (Pubitemid 36512831)
-
(2003)
American Journal of Pathology
, vol.162
, Issue.5
, pp. 1495-1502
-
-
Chilosi, M.1
Poletti, V.2
Zamo, A.3
Lestani, M.4
Montagna, L.5
Piccoli, P.6
Pedron, S.7
Bertaso, M.8
Scarpa, A.9
Murer, B.10
Cancellier, A.11
Maestro, R.12
Semenzato, G.13
Doglioni, C.14
-
95
-
-
33746977705
-
Migratory marker expression in fibroblast foci of idiopathic pulmonary fibrosis
-
Chilosi M, Zamo A, Doglioni C, et al. Migratory marker expression in fibroblast foci of idiopathic pulmonary fibrosis. Respir Res 2006; 7: 95.
-
(2006)
Respir Res
, vol.7
, pp. 95
-
-
Chilosi, M.1
Zamo, A.2
Doglioni, C.3
-
96
-
-
77955481200
-
Endothelialmesenchymal transition in bleomycin-induced pulmonary fibrosis
-
Hashimoto N, Phan SH, Imaizumi K, et al. Endothelialmesenchymal transition in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 2009; 43 (2): 161-72.
-
(2009)
Am J Respir Cell Mol Biol
, vol.43
, Issue.2
, pp. 161-172
-
-
Hashimoto, N.1
Phan, S.H.2
Imaizumi, K.3
-
97
-
-
0037378123
-
Unique structural features that influence neutrophil emigration into the lung
-
Burns AR, Smith CW, Walker DC. Unique structural features that influence neutrophil emigration into the lung. Physiol Rev 2003; 83 (2): 309-36. (Pubitemid 36378675)
-
(2003)
Physiological Reviews
, vol.83
, Issue.2
, pp. 309-336
-
-
Burns, A.R.1
Smith, C.W.2
Walker, D.C.3
-
98
-
-
33644845306
-
Alteration of fibroblast architecture and loss of basal lamina apertures in human emphysematous lung
-
DOI 10.1164/rccm.200509-1434OC
-
Sirianni FE, Milaninezhad A, Chu FS, et al. Alteration of fibroblast architecture and loss of Basal lamina apertures in human emphysematous lung. Am J Respir Crit Care Med 2006; 173 (6): 632-8. (Pubitemid 43363804)
-
(2006)
American Journal of Respiratory and Critical Care Medicine
, vol.173
, Issue.6
, pp. 632-638
-
-
Sirianni, F.E.1
Milaninezhad, A.2
Chu, F.S.F.3
Walker, D.C.4
-
99
-
-
34447309766
-
The myofibroblast: One function, multiple origins
-
DOI 10.2353/ajpath.2007.070112
-
Hinz B, Phan SH, Thannickal VJ, et al. The myofibroblast: one function, multiple origins. Am J Pathol 2007; 170 (6): 1807-16. (Pubitemid 47339255)
-
(2007)
American Journal of Pathology
, vol.170
, Issue.6
, pp. 1807-1816
-
-
Hinz, B.1
Phan, S.H.2
Thannickal, V.J.3
Galli, A.4
Bochaton-Piallat, M.-L.5
Gabbiani, G.6
-
100
-
-
25144471827
-
Loss of fibroblast Thy-1 expression correlates with lung fibrogenesis
-
Hagood JS, Prabhakaran P, Kumbla P, et al. Loss of fibroblast Thy-1 expression correlates with lung fibrogenesis. Am J Pathol 2005; 167 (2): 365-79. (Pubitemid 43026094)
-
(2005)
American Journal of Pathology
, vol.167
, Issue.2
, pp. 365-379
-
-
Hagood, J.S.1
Prabhakaran, P.2
Kumbla, P.3
Salazar, L.4
MacEwen, M.W.5
Barker, T.H.6
Ortiz, L.A.7
Schoeb, T.8
Siegal, G.P.9
Alexander, C.B.10
Pardo, A.11
Selman, M.12
-
101
-
-
3242797250
-
Thy-1 expression regulates the ability of rat lung fibroblasts to activate transforming growth factor-β in response to fibrogenic stimuli
-
Zhou Y, Hagood JS, Murphy-Ullrich JE. Thy-1 expression regulates the ability of rat lung fibroblasts to activate transforming growth factor-beta in response to fibrogenic stimuli. Am J Pathol 2004; 165 (2): 659-69. (Pubitemid 38971395)
-
(2004)
American Journal of Pathology
, vol.165
, Issue.2
, pp. 659-669
-
-
Zhou, Y.1
Hagood, J.S.2
Murphy-Ullrich, J.E.3
-
102
-
-
33749077290
-
Thy-1, a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine/growth factor responses
-
DOI 10.1016/j.bbamcr.2006.08.008, PII S0167488906002230
-
Rege TA, Hagood JS. Thy-1, a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine/growth factor responses. Biochim Biophys Acta 2006; 1763 (10): 991-9. (Pubitemid 44466122)
-
(2006)
Biochimica et Biophysica Acta - Molecular Cell Research
, vol.1763
, Issue.10
, pp. 991-999
-
-
Rege, T.A.1
Hagood, J.S.2
-
103
-
-
58249098406
-
Latent transforming growth factor-beta-binding protein-4 regulates transforming growth factor-beta1 bioavailability for activation by fibrogenic lung fibroblasts in response to bleomycin
-
Zhou Y, Koli K, Hagood JS, et al. Latent transforming growth factor-beta-binding protein-4 regulates transforming growth factor-beta1 bioavailability for activation by fibrogenic lung fibroblasts in response to bleomycin. Am J Pathol 2009; 174 (1): 21-33.
-
(2009)
Am J Pathol
, vol.174
, Issue.1
, pp. 21-33
-
-
Zhou, Y.1
Koli, K.2
Hagood, J.S.3
-
104
-
-
1942435249
-
Micromanagers of gene expression: The potentially widespread influence of metazoan microRNAs
-
Bartel DP, Chen CZ. Micromanagers of gene expression: the potentially widespread influence of metazoan micro- RNAs. Nat Rev Genet 2004; 5 (5): 396-400. (Pubitemid 38529411)
-
(2004)
Nature Reviews Genetics
, vol.5
, Issue.5
, pp. 396-400
-
-
Bartel, D.P.1
Chen, C.-Z.2
-
105
-
-
51349141401
-
Dysregulation ofmicroRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
-
van Rooij E, Sutherland LB, Thatcher JE, et al. Dysregulation ofmicroRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 2008; 105 (35): 13027-32.
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, Issue.35
, pp. 13027-32
-
-
Van Rooij, E.1
Sutherland, L.B.2
Thatcher, J.E.3
-
106
-
-
57749168828
-
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
-
Thum T, Gross C, Fiedler J, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008; 456 (7224): 980-4.
-
(2008)
Nature
, vol.456
, Issue.7224
, pp. 980-984
-
-
Thum, T.1
Gross, C.2
Fiedler, J.3
-
107
-
-
77955399498
-
Inhibition and role of let-7d in idiopathic pulmonary fibrosis
-
Pandit KV, Corcoran D, Yousef H, et al. Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2010; 182 (2): 220-9.
-
(2010)
Am J Respir Crit Care Med
, vol.182
, Issue.2
, pp. 220-229
-
-
Pandit, K.V.1
Corcoran, D.2
Yousef, H.3
-
108
-
-
77955373730
-
MiR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis
-
Liu G, Friggeri A, Yang Y, et al. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 2010; 207 (8): 1589-97.
-
(2010)
J Exp Med
, vol.207
, Issue.8
, pp. 1589-1597
-
-
Liu, G.1
Friggeri, A.2
Yang, Y.3
-
109
-
-
33847682663
-
MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-β-induced collagen expression via inhibition of E-box repressors
-
DOI 10.1073/pnas.0611192104
-
Kato M, Zhang J, Wang M, et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-betainduced collagen expression via inhibition of E-box repressors. Proc Natl Acad SciUS A 2007; 104 (9): 3432-7. (Pubitemid 46364176)
-
(2007)
Proceedings of the National Academy of Sciences of the United States of America
, vol.104
, Issue.9
, pp. 3432-3437
-
-
Kato, M.1
Zhang, J.2
Wang, M.3
Lanting, L.4
Yuan, H.5
Rossi, J.J.6
Natarajan, R.7
-
110
-
-
67651111989
-
Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines
-
Shan H, Zhang Y, Lu Y, et al. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc Res 2009; 83 (3): 465-72.
-
(2009)
Cardiovasc Res
, vol.83
, Issue.3
, pp. 465-472
-
-
Shan, H.1
Zhang, Y.2
Lu, Y.3
-
111
-
-
59849128881
-
MiR-133 and miR-30 regulate connective tissue growth factor: Implications for a role of microRNAs in myocardial matrix remodeling
-
6p following 178
-
Duisters RF, Tijsen AJ, Schroen B, et al. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res 2009; 104 (2): 170-8, 6p following 178.
-
(2009)
Circ Res
, vol.104
, Issue.2
, pp. 170-178
-
-
Duisters, R.F.1
Tijsen, A.J.2
Schroen, B.3
-
112
-
-
80051655553
-
MIR-29 is a major regulator of genes associated with pulmonary fibrosis
-
Epub 2010 Oct 22
-
Cushing L, Kuang PP, Qian J, et al. MIR-29 is a major regulator of genes associated with pulmonary fibrosis. Am J Respir Cell Mol Biol. Epub 2010 Oct 22.
-
Am J Respir Cell Mol Biol
-
-
Cushing, L.1
Kuang, P.P.2
Qian, J.3
-
113
-
-
75649113377
-
Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21
-
Sheedy FJ, Palsson-McDermott E, Hennessy EJ, et al. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 2010; 11 (2): 141-7.
-
(2010)
Nat Immunol
, vol.11
, Issue.2
, pp. 141-147
-
-
Sheedy, F.J.1
Palsson-Mcdermott, E.2
Hennessy, E.J.3
-
114
-
-
77954797933
-
Ischaemic preconditioningregulated miR-21 protects heart against ischaemia/ reperfusion injury via anti-apoptosis through its target PDCD4
-
Cheng Y, Zhu P, Yang J, et al. Ischaemic preconditioningregulated miR-21 protects heart against ischaemia/ reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovasc Res 2010; 87 (3): 431-9.
-
(2010)
Cardiovasc Res
, vol.87
, Issue.3
, pp. 431-439
-
-
Cheng, Y.1
Zhu, P.2
Yang, J.3
-
115
-
-
77956501846
-
Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21
-
Hatley ME, Patrick DM, Garcia MR, et al. Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell 2010; 18 (3): 282-93.
-
(2010)
Cancer Cell
, vol.18
, Issue.3
, pp. 282-293
-
-
Hatley, M.E.1
Patrick, D.M.2
Garcia, M.R.3
-
116
-
-
62349141343
-
MicroRNA expression in response to murine myocardial infarction: MiR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue
-
Roy S, Khanna S, Hussain SR, et al. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res 2009; 82 (1): 21-9.
-
(2009)
Cardiovasc Res
, vol.82
, Issue.1
, pp. 21-29
-
-
Roy, S.1
Khanna, S.2
Hussain, S.R.3
-
117
-
-
67650085171
-
TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN
-
Kato M, Putta S, Wang M, et al. TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol 2009; 11 (7): 881-9.
-
(2009)
Nat Cell Biol
, vol.11
, Issue.7
, pp. 881-889
-
-
Kato, M.1
Putta, S.2
Wang, M.3
-
118
-
-
68249126627
-
MicroRNA MiR-17 retards tissue growth and represses fibronectin expression
-
Shan SW, Lee DY, Deng Z, et al. MicroRNA MiR-17 retards tissue growth and represses fibronectin expression. Nat Cell Biol 2009; 11 (8): 1031-8.
-
(2009)
Nat Cell Biol
, vol.11
, Issue.8
, pp. 1031-1038
-
-
Shan, S.W.1
Lee, D.Y.2
Deng, Z.3
-
119
-
-
68449097267
-
MiR-145 and miR-143 regulate smooth muscle cell fate and plasticity
-
Cordes KR, Sheehy NT, White MP, et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009; 460 (7256): 705-10.
-
(2009)
Nature
, vol.460
, Issue.7256
, pp. 705-710
-
-
Cordes, K.R.1
Sheehy, N.T.2
White, M.P.3
-
120
-
-
69249202575
-
Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: Implication in epithelial-mesenchymal interactions
-
Pottier N, Maurin T, Chevalier B, et al. Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions. PLoS One 2009; 4 (8): e6718.
-
(2009)
PLoS One
, vol.4
, Issue.8
-
-
Pottier, N.1
Maurin, T.2
Chevalier, B.3
-
121
-
-
33745826614
-
MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblast
-
DOI 10.1074/jbc.M601496200
-
Martin MM, Lee EJ, Buckenberger JA, et al. MicroRNA- 155 regulates human angiotensin II type 1 receptor expression in fibroblasts. J Biol Chem 2006; 281 (27): 18277-84. (Pubitemid 44035484)
-
(2006)
Journal of Biological Chemistry
, vol.281
, Issue.27
, pp. 18277-18284
-
-
Martin, M.M.1
Lee, E.J.2
Buckenberger, J.A.3
Schmittgen, T.D.4
Elton, T.S.5
-
122
-
-
43049103824
-
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
-
DOI 10.1038/ncb1722, PII NCB1722
-
Gregory PA, Bert AG, Paterson EL, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10 (5): 593-601. (Pubitemid 351627379)
-
(2008)
Nature Cell Biology
, vol.10
, Issue.5
, pp. 593-601
-
-
Gregory, P.A.1
Bert, A.G.2
Paterson, E.L.3
Barry, S.C.4
Tsykin, A.5
Farshid, G.6
Vadas, M.A.7
Khew-Goodall, Y.8
Goodall, G.J.9
-
123
-
-
41649091906
-
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
-
DOI 10.1101/gad.1640608
-
Park SM, Gaur AB, Lengyel E, et al. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 2008; 22 (7): 894-907. (Pubitemid 351482843)
-
(2008)
Genes and Development
, vol.22
, Issue.7
, pp. 894-907
-
-
Park, S.-M.1
Gaur, A.B.2
Lengyel, E.3
Peter, M.E.4
-
124
-
-
47249091921
-
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2
-
Korpal M, Lee ES, Hu G, et al. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 2008; 283 (22): 14910-4.
-
(2008)
J Biol Chem
, vol.283
, Issue.22
, pp. 14910-4
-
-
Korpal, M.1
Lee, E.S.2
Hu, G.3
-
125
-
-
65649146879
-
The mechanical integrin cycle
-
Puklin-Faucher E, Sheetz MP. The mechanical integrin cycle. J Cell Sci 2009; 122 (Pt 2): 179-86.
-
(2009)
J Cell Sci
, vol.122
, Issue.PART 2
, pp. 179-186
-
-
Puklin-Faucher, E.1
Sheetz, M.P.2
-
126
-
-
37249044357
-
Myofibroblast contraction activates latent TGF-β1 from the extracellular matrix
-
DOI 10.1083/jcb.200704042
-
Wipff PJ, Rifkin DB, Meister JJ, et al. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol 2007; 179 (6): 1311-23. (Pubitemid 350277747)
-
(2007)
Journal of Cell Biology
, vol.179
, Issue.6
, pp. 1311-1323
-
-
Wipff, P.-J.1
Rifkin, D.B.2
Meister, J.-J.3
Hinz, B.4
-
127
-
-
0028906190
-
Processing of transforming growth factor beta 1 precursor by human furin convertase
-
Dubois CM, Laprise MH, Blanchette F, et al. Processing of transforming growth factor beta 1 precursor by human furin convertase. J Biol Chem 1995; 270 (18): 10618-24.
-
(1995)
J Biol Chem
, vol.270
, Issue.18
, pp. 10618-24
-
-
Dubois, C.M.1
Laprise, M.H.2
Blanchette, F.3
-
128
-
-
0021173481
-
Normal embryo fibroblasts release transforming growth factors in a latent form
-
Lawrence DA, Pircher R, Kryceve-Martinerie C, et al. Normal embryo fibroblasts release transforming growth factors in a latent form. J Cell Physiol 1984; 121 (1): 184-8. (Pubitemid 14017248)
-
(1984)
Journal of Cellular Physiology
, vol.121
, Issue.1
, pp. 184-188
-
-
Lawrence, D.A.1
Pircher, R.2
Kryceve-Martinerie, C.3
Jullien, P.4
-
129
-
-
0022335318
-
Conversion of a high molecular weight latent β-TGF from chicken embryo fibroblasts into a low molecular weight active β-TGF under acidic conditions
-
Lawrence DA, Pircher R, Jullien P. Conversion of a high molecular weight latent beta-TGF from chicken embryo fibroblasts into a low molecular weight active beta-TGF under acidic conditions. Biochem Biophys Res Commun 1985; 133 (3): 1026-34. (Pubitemid 16142882)
-
(1985)
Biochemical and Biophysical Research Communications
, vol.133
, Issue.3
, pp. 1026-1034
-
-
Lawrence, D.A.1
Pircher, R.2
Jullien, P.3
-
130
-
-
0034865421
-
Novel non-TGF-β-binding splice variant of LTBP-4 in human cells and tissues provides means to decrease TGF-β deposition
-
Koli K, Saharinen J, Karkkainen M, et al. Novel non- TGF-beta-binding splice variant of LTBP-4 in human cells and tissues provides means to decrease TGF-beta deposition. J Cell Sci 2001; 114 (Pt 15): 2869-78. (Pubitemid 32785465)
-
(2001)
Journal of Cell Science
, vol.114
, Issue.15
, pp. 2869-2878
-
-
Koli, K.1
Saharinen, J.2
Karkkainen, M.3
Keski-Oja, J.4
-
131
-
-
0037439630
-
Making sense of latent TGFβ activation
-
DOI 10.1242/jcs.00229
-
Annes JP, Munger JS, Rifkin DB. Making sense of latent TGFbeta activation. J Cell Sci 2003; 116 (Pt 2): 217-24. (Pubitemid 36163863)
-
(2003)
Journal of Cell Science
, vol.116
, Issue.2
, pp. 217-224
-
-
Annes, J.P.1
Munger, J.S.2
Rifkin, D.B.3
-
132
-
-
3042838388
-
Latent TGF-β binding proteins: Extracellular matrix association and roles in TGF-β activation
-
DOI 10.1080/10408360490460933
-
Hyytiainen M, Penttinen C, Keski-Oja J. Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation. Crit Rev Clin Lab Sci 2004; 41 (3): 233-64. (Pubitemid 38888060)
-
(2004)
Critical Reviews in Clinical Laboratory Sciences
, vol.41
, Issue.3
, pp. 233-264
-
-
Hyytiainen, M.1
Penttinen, C.2
Keski-Oja, J.3
-
133
-
-
5444255239
-
Disruption of LTBP-4 function reduces TGF-β activation and enhances BMP-4 signaling in the lung
-
DOI 10.1083/jcb.200403067
-
Koli K, Wempe F, Sterner-Kock A, et al. Disruption of LTBP-4 function reduces TGF-beta activation and enhances BMP-4 signaling in the lung. J Cell Biol 2004; 167 (1): 123-33. (Pubitemid 39363420)
-
(2004)
Journal of Cell Biology
, vol.167
, Issue.1
, pp. 123-133
-
-
Koli, K.1
Wempe, F.2
Sterner-Kock, A.3
Kantola, A.4
Komor, M.5
Hofmann, W.-K.6
Von Melchner, H.7
Keski-Oja, J.8
-
134
-
-
0033524949
-
The integrin αvβ6 binds and activates latent TGFβ1: A mechanism for regulating pulmonary inflammation and fibrosis
-
DOI 10.1016/S0092-8674(00)80545-0
-
Munger JS, Huang X, Kawakatsu H, et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999; 96 (3): 319-28. (Pubitemid 29077586)
-
(1999)
Cell
, vol.96
, Issue.3
, pp. 319-328
-
-
Munger, J.S.1
Huang, X.2
Kawakatsu, H.3
Griffiths, M.J.D.4
Dalton, S.L.5
Wu, J.6
Pittet, J.-F.7
Kaminski, N.8
Garat, C.9
Matthay, M.A.10
Rifkin, D.B.11
Sheppard, D.12
-
135
-
-
0030800795
-
Adenovector-mediated gene transfer of active transforming growth factor- β1 induces prolonged severe fibrosis in rat lung
-
Sime PJ, Xing Z, Graham FL, et al. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest 1997; 100 (4): 768-76. (Pubitemid 27371693)
-
(1997)
Journal of Clinical Investigation
, vol.100
, Issue.4
, pp. 768-776
-
-
Sime, P.J.1
Xing, Z.2
Graham, F.L.3
Csaky, K.G.4
Gauldie, J.5
-
136
-
-
0032886794
-
Activation of rat alveolar macrophage-derived latent transforming growth factor β-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36
-
Yehualaeshet T, O'Connor R, Green-Johnson J, et al. Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36. Am J Pathol 1999; 155 (3): 841-51. (Pubitemid 29426830)
-
(1999)
American Journal of Pathology
, vol.155
, Issue.3
, pp. 841-851
-
-
Yehualaeshet, T.1
O'Connor, R.2
Green-Johnson, J.3
Mai, S.4
Silverstein, R.5
Murphy-Ullrich, J.E.6
Khalil, N.7
-
137
-
-
34548173504
-
TGF-β, Smad3 and the process of progressive fibrosis
-
Gauldie J, Bonniaud P, Sime P, et al. TGF-beta, Smad3 and the process of progressive fibrosis. Biochem Soc Trans 2007; 35 (Pt 4): 661-4. (Pubitemid 47310335)
-
(2007)
Biochemical Society Transactions
, vol.35
, Issue.4
, pp. 661-664
-
-
Gauldie, J.1
Bonniaud, P.2
Sime, P.3
Ask, K.4
Kolb, M.5
-
138
-
-
0026210618
-
Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis
-
Khalil N, O'Connor RN, Unruh HW, et al. Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 1991; 5 (2): 155-62.
-
(1991)
Am J Respir Cell Mol Biol
, vol.5
, Issue.2
, pp. 155-162
-
-
Khalil, N.1
O'Connor, R.N.2
Unruh, H.W.3
-
139
-
-
67749132419
-
TGF-beta and fibrosis in different organs: Molecular pathway imprints
-
Pohlers D, Brenmoehl J, Loffler I, et al. TGF-beta and fibrosis in different organs: molecular pathway imprints. Biochim Biophys Acta 2009; 1792 (8): 746-56.
-
(2009)
Biochim Biophys Acta
, vol.1792
, Issue.8
, pp. 746-756
-
-
Pohlers, D.1
Brenmoehl, J.2
Loffler, I.3
-
140
-
-
30944466813
-
Smad3 is key to TGF-β-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis
-
DOI 10.1016/j.cytogfr.2005.09.008, PII S1359610105001127
-
Roberts AB, Tian F, Byfield SD, et al. Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis. Cytokine Growth Factor Rev 2006; 17 (1-2): 19-27. (Pubitemid 43117513)
-
(2006)
Cytokine and Growth Factor Reviews
, vol.17
, Issue.1-2
, pp. 19-27
-
-
Roberts, A.B.1
Tian, F.2
Byfield, S.D.3
Stuelten, C.4
Ooshima, A.5
Saika, S.6
Flanders, K.C.7
-
141
-
-
55749109860
-
In vitro and in vivo evidence for shear-induced activation of latent transforming growth factor-beta1
-
Ahamed J, Burg N, Yoshinaga K, et al. In vitro and in vivo evidence for shear-induced activation of latent transforming growth factor-beta1. Blood 2008; 112 (9): 3650-60.
-
(2008)
Blood
, vol.112
, Issue.9
, pp. 3650-3660
-
-
Ahamed, J.1
Burg, N.2
Yoshinaga, K.3
-
142
-
-
68949162163
-
In vitro and in vivo evidence that thrombospondin-1 (TSP-1) contributes to stirring- and shear-dependent activation of platelet-derived TGF-beta1
-
Ahamed J, Janczak CA, Wittkowski KM, et al. In vitro and in vivo evidence that thrombospondin-1 (TSP-1) contributes to stirring- and shear-dependent activation of platelet-derived TGF-beta1. PLoS One 2009; 4 (8): e6608.
-
(2009)
PLoS One
, vol.4
, Issue.8
-
-
Ahamed, J.1
Janczak, C.A.2
Wittkowski, K.M.3
-
143
-
-
0030058699
-
Association of the small latent transforming growth factor-β with an eight cysteine repeat of its binding protein LTBP-1
-
Saharinen J, Taipale J, Keski-Oja J. Association of the small latent transforming growth factor-beta with an eight cysteine repeat of its binding protein LTBP-1. EMBO J 1996; 15 (2): 245-53. (Pubitemid 26029204)
-
(1996)
EMBO Journal
, vol.15
, Issue.2
, pp. 245-253
-
-
Saharinen, J.1
Taipale, J.2
Keski-Oja, J.3
-
144
-
-
0035153291
-
Latent TGF-β binding protein LTBP-1 contains three potential extracellular matrix interacting domains
-
Unsold C, Hyytiainen M, Bruckner-Tuderman L, et al. Latent TGF-beta binding protein LTBP-1 contains three potential extracellular matrix interacting domains. J Cell Sci 2001; 114 (Pt 1): 187-97. (Pubitemid 32118068)
-
(2001)
Journal of Cell Science
, vol.114
, Issue.1
, pp. 187-197
-
-
Unsold, C.1
Hyytiainen, M.2
Bruckner-Tuderman, L.3
Keski-Oja, J.4
-
145
-
-
0037462678
-
Latent transforming growth factor β-binding protein 1 interacts with fibrillin and is a microfibril-associated protein
-
DOI 10.1074/jbc.M209256200
-
Isogai Z, Ono RN, Ushiro S, et al. Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein. J Biol Chem 2003; 278 (4): 2750-7. (Pubitemid 36801356)
-
(2003)
Journal of Biological Chemistry
, vol.278
, Issue.4
, pp. 2750-2757
-
-
Isogai, Z.1
Ono, R.N.2
Ushiro, S.3
Keene, D.R.4
Chen, Y.5
Mazzieri, R.6
Charbonneau, N.L.7
Reinhardt, D.P.8
Rifkin, D.B.9
Sakai, L.Y.10
-
146
-
-
33745183811
-
Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury
-
Jenkins RG, Su X, Su G, et al. Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. J Clin Invest 2006; 116 (6): 1606-14.
-
(2006)
J Clin Invest
, vol.116
, Issue.6
, pp. 1606-1614
-
-
Jenkins, R.G.1
Su, X.2
Su, G.3
-
147
-
-
27644538315
-
Integrin-mediated activation of latent transforming growth factor β
-
DOI 10.1007/s10555-005-5131-6
-
Sheppard D. Integrin-mediated activation of latent transforming growth factor beta. Cancer Metastasis Rev 2005; 24 (3): 395-402. (Pubitemid 41569979)
-
(2005)
Cancer and Metastasis Reviews
, vol.24
, Issue.3
, pp. 395-402
-
-
Sheppard, D.1
-
148
-
-
77954568888
-
Thy-1-integrin alpha v beta5 interactions inhibit lung fibroblast contractioninduced latent transforming growth factor-beta1 activation and myofibroblast differentiation
-
Zhou Y, Hagood JS, Lu B, et al. Thy-1-integrin alpha v beta5 interactions inhibit lung fibroblast contractioninduced latent transforming growth factor-beta1 activation and myofibroblast differentiation. J Biol Chem 2010; 285 (29): 22382-93.
-
(2010)
J Biol Chem
, vol.285
, Issue.29
, pp. 22382-93
-
-
Zhou, Y.1
Hagood, J.S.2
Lu, B.3
-
149
-
-
38949089708
-
Focal adhesion kinase: Targeting adhesion signaling pathways for therapeutic intervention
-
DOI 10.1158/1078-0432.CCR-07-2220
-
Parsons JT, Slack-Davis J, Tilghman R, et al. Focal adhesion kinase: targeting adhesion signaling pathways for therapeutic intervention. Clin Cancer Res 2008; 14 (3): 627-32. (Pubitemid 351231140)
-
(2008)
Clinical Cancer Research
, vol.14
, Issue.3
, pp. 627-632
-
-
Parsons, J.T.1
Slack-Davis, J.2
Tilghman, R.3
Roberts, W.G.4
-
150
-
-
0038823614
-
Myofibroblast differentiation by transforming growth factor-β1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase
-
DOI 10.1074/jbc.M208544200
-
Thannickal VJ, Lee DY, White ES, et al. Myofibroblast differentiation by transforming growth factor-beta1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase. J Biol Chem 2003; 278 (14): 12384-9. (Pubitemid 36800223)
-
(2003)
Journal of Biological Chemistry
, vol.278
, Issue.14
, pp. 12384-12389
-
-
Thannickal, V.J.1
Lee, D.Y.2
White, E.S.3
Cui, Z.4
Larios, J.M.5
Chacon, R.6
Horowitz, J.C.7
Day, R.M.8
Thomas, P.E.9
-
151
-
-
55249089456
-
Focal adhesion kinase (FAK)-related non-kinase inhibits myofibroblast differentiation through differential MAPK activation in a FAK-dependent manner
-
Ding Q, Gladson CL, Wu H, et al. Focal adhesion kinase (FAK)-related non-kinase inhibits myofibroblast differentiation through differential MAPK activation in a FAK-dependent manner. J Biol Chem 2008; 283 (40): 26839-49.
-
(2008)
J Biol Chem
, vol.283
, Issue.40
, pp. 26839-49
-
-
Ding, Q.1
Gladson, C.L.2
Wu, H.3
-
152
-
-
77952763874
-
Downregulation of FAKrelated non-kinase mediates the migratory phenotype of human fibrotic lung fibroblasts
-
Cai GQ, Zheng A, Tang Q, et al. Downregulation of FAKrelated non-kinase mediates the migratory phenotype of human fibrotic lung fibroblasts. Exp Cell Res 2010; 316 (9): 1600-9.
-
(2010)
Exp Cell Res
, vol.316
, Issue.9
, pp. 1600-1609
-
-
Cai, G.Q.1
Zheng, A.2
Tang, Q.3
-
153
-
-
33847171545
-
Combinatorial activation of FAK and AKT by transforming growth factor-β1 confers an anoikis-resistant phenotype to myofibroblasts
-
DOI 10.1016/j.cellsig.2006.10.001, PII S0898656806002701
-
Horowitz JC, Rogers DS, Sharma V, et al. Combinatorial activation of FAK and AKT by transforming growth factor-beta1 confers an anoikis-resistant phenotype to myofibroblasts. Cell Signal 2007; 19 (4): 761-71. (Pubitemid 46290691)
-
(2007)
Cellular Signalling
, vol.19
, Issue.4
, pp. 761-771
-
-
Horowitz, J.C.1
Rogers, D.S.2
Sharma, V.3
Vittal, R.4
White, E.S.5
Cui, Z.6
Thannickal, V.J.7
-
154
-
-
0037509990
-
Focal adhesion kinase: The first ten years
-
DOI 10.1242/jcs.00373
-
Parsons JT. Focal adhesion kinase: the first ten years. J Cell Sci 2003; 116 (Pt 8): 1409-16. (Pubitemid 36527488)
-
(2003)
Journal of Cell Science
, vol.116
, Issue.8
, pp. 1409-1416
-
-
Parsons, J.T.1
-
155
-
-
40149090411
-
Src kinases in systemic sclerosis: Central roles in fibroblast activation and in skin fibrosis
-
DOI 10.1002/art.23436
-
Skhirtladze C, Distler O, Dees C, et al. Src kinases in systemic sclerosis: central roles in fibroblast activation and in skin fibrosis. Arthritis Rheum 2008; 58 (5): 1475-84. (Pubitemid 351705937)
-
(2008)
Arthritis and Rheumatism
, vol.58
, Issue.5
, pp. 1475-1484
-
-
Skhirtladze, C.1
Distler, O.2
Dees, C.3
Akhmetshina, A.4
Busch, N.5
Venalis, P.6
Zwerina, J.7
Spriewald, B.8
Pileckyte, M.9
Schett, G.10
Distler, J.H.W.11
-
156
-
-
58149234456
-
Protein kinase inhibitors in the treatment of pulmonary fibrosis
-
Garneau-Tsodikova S, Thannickal VJ. Protein kinase inhibitors in the treatment of pulmonary fibrosis. Curr Med Chem 2008; 15 (25): 2632-40.
-
(2008)
Curr Med Chem
, vol.15
, Issue.25
, pp. 2632-2640
-
-
Garneau-Tsodikova, S.1
Thannickal, V.J.2
-
157
-
-
0034747099
-
TGF-β1-induced PAI-1 gene expression requires MEK activity and cell-to-substrate adhesion
-
Kutz SM, Hordines J, McKeown-Longo PJ, et al. TGFbeta1- induced PAI-1 gene expression requires MEK activity and cell-to-substrate adhesion. J Cell Sci 2001; 114 (Pt 21): 3905-14. (Pubitemid 33094705)
-
(2001)
Journal of Cell Science
, vol.114
, Issue.21
, pp. 3905-3914
-
-
Kutz, S.M.1
Hordines, J.2
McKeown-Longo, P.J.3
Higgins, P.J.4
-
158
-
-
0034023127
-
Role of Ras and Mapks in TGFβ signaling
-
DOI 10.1016/S1359-6101(99)00026-X, PII S135961019900026X
-
Mulder KM. Role of Ras and Mapks in TGFbeta signaling. Cytokine Growth Factor Rev 2000; 11 (1-2): 23-35. (Pubitemid 30169723)
-
(2000)
Cytokine and Growth Factor Reviews
, vol.11
, Issue.1-2
, pp. 23-35
-
-
Mulder, K.M.1
-
159
-
-
0141679506
-
Phosphorylation of threonine 276 in Smad4 is involved in transforming growth factor-β-induced nuclear accumulation
-
Roelen BA, Cohen OS, Raychowdhury MK, et al. Phosphorylation of threonine 276 in Smad4 is involved in transforming growth factor-beta-induced nuclear accumulation. Am J Physiol Cell Physiol 2003; 285 (4): C823-30. (Pubitemid 37158807)
-
(2003)
American Journal of Physiology - Cell Physiology
, vol.285
, Issue.4
-
-
Roelen, B.A.J.1
Cohen, O.S.2
Raychowdhury, M.K.3
Chadee, D.N.4
Zhang, Y.5
Kyriakis, J.M.6
Alessandrini, A.A.7
Lin, H.Y.8
-
160
-
-
0141866937
-
P38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts
-
DOI 10.1053/jhep.2003.50384
-
Furukawa F, Matsuzaki K, Mori S, et al. p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts. Hepatology 2003; 38 (4): 879-89. (Pubitemid 37221671)
-
(2003)
Hepatology
, vol.38
, Issue.4
, pp. 879-889
-
-
Furukawa, F.1
Matsuzaki, K.2
Mori, S.3
Tahashi, Y.4
Yoshida, K.5
Sugano, Y.6
Yamagata, H.7
Matsushita, M.8
Seki, T.9
Inagaki, Y.10
Nishizawa, M.11
Fujisawa, J.12
Inoue, K.13
-
161
-
-
74249112787
-
Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection
-
Lanford RE, Hildebrandt-Eriksen ES, Petri A, et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010; 327 (5962): 198-201.
-
(2010)
Science
, vol.327
, Issue.5962
, pp. 198-201
-
-
Lanford, R.E.1
Hildebrandt-Eriksen, E.S.2
Petri, A.3
-
162
-
-
78651247933
-
Micro- RNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-alpha- PU.1 pathway
-
Ponomarev ED, Veremeyko T, Barteneva N, et al. Micro- RNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-alpha- PU.1 pathway. Nat Med 2010; 17 (1): 64-70.
-
(2010)
Nat Med
, vol.17
, Issue.1
, pp. 64-70
-
-
Ponomarev, E.D.1
Veremeyko, T.2
Barteneva, N.3
-
163
-
-
68049083397
-
MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation
-
Cheng Y, Liu X, Yang J, et al. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 2009; 105 (2): 158-66.
-
(2009)
Circ Res
, vol.105
, Issue.2
, pp. 158-166
-
-
Cheng, Y.1
Liu, X.2
Yang, J.3
-
164
-
-
0036277026
-
Myofibroblasts and mechano: Regulation of connective tissue remodelling
-
DOI 10.1038/nrm809
-
Tomasek JJ, Gabbiani G, Hinz B, et al. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002; 3 (5): 349-63. (Pubitemid 34619269)
-
(2002)
Nature Reviews Molecular Cell Biology
, vol.3
, Issue.5
, pp. 349-363
-
-
Tomasek, J.J.1
Gabbiani, G.2
Hinz, B.3
Chaponnier, C.4
Brown, R.A.5
-
165
-
-
9444242736
-
Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho- kinase)
-
Kimura K, Ito M, Amano M, et al. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rhokinase). Science 1996; 273 (5272): 245-8. (Pubitemid 26285892)
-
(1996)
Science
, vol.273
, Issue.5272
, pp. 245-248
-
-
Kimura, K.1
Ito, M.2
Amano, M.3
Chihara, K.4
Fukata, Y.5
Nakafuku, M.6
Yamamori, B.7
Feng, J.8
Nakano, T.9
Okawa, K.10
Iwamatsu, A.11
Kaibuchi, K.12
-
166
-
-
0033615977
-
Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase by Rho-kinase in vivo
-
Kawano Y, Fukata Y, Oshiro N, et al. Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase by Rho-kinase in vivo. J Cell Biol 1999; 147 (5): 1023-38.
-
(1999)
J Cell Biol
, vol.147
, Issue.5
, pp. 1023-1038
-
-
Kawano, Y.1
Fukata, Y.2
Oshiro, N.3
-
167
-
-
31544433970
-
Molecular mechanisms and therapeutic strategies of chronic renal injury: Renoprotective effect of rho-kinase inhibitor in hypertensive glomerulosclerosis
-
DOI 10.1254/jphs.FMJ05003X5
-
Nishikimi T, Matsuoka H. Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effect of rho-kinase inhibitor in hypertensive glomerulosclerosis. J Pharmacol Sci 2006; 100 (1): 22-8. (Pubitemid 43161610)
-
(2006)
Journal of Pharmacological Sciences
, vol.100
, Issue.1
, pp. 22-28
-
-
Nishikimi, T.1
Matsuoka, H.2
-
169
-
-
53849089211
-
Therapeutic potential of RhoA/Rho kinase inhibitors in pulmonary hypertension
-
Oka M, Fagan KA, Jones PL, et al. Therapeutic potential of RhoA/Rho kinase inhibitors in pulmonary hypertension. Br J Pharmacol 2008; 155 (4): 444-54.
-
(2008)
Br J Pharmacol
, vol.155
, Issue.4
, pp. 444-454
-
-
Oka, M.1
Fagan, K.A.2
Jones, P.L.3
-
170
-
-
43049096072
-
Rho kinase inhibitors: A novel therapeutical intervention in asthma?
-
Schaafsma D, Gosens R, Zaagsma J, et al. Rho kinase inhibitors: a novel therapeutical intervention in asthma? Eur J Pharmacol 2008; 585 (2-3): 398-406.
-
(2008)
Eur J Pharmacol
, vol.585
, Issue.2-3
, pp. 398-406
-
-
Schaafsma, D.1
Gosens, R.2
Zaagsma, J.3
-
171
-
-
0036236193
-
Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction
-
DOI 10.1046/j.1523-1755.2002.00328.x
-
Nagatoya K, Moriyama T, Kawada N, et al. Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction. Kidney Int 2002; 61 (5): 1684-95. (Pubitemid 34437922)
-
(2002)
Kidney International
, vol.61
, Issue.5
, pp. 1684-1695
-
-
Nagatoya, K.1
Moriyama, T.2
Kawada, N.3
Takeji, M.4
Oseto, S.5
Murozono, T.6
Ando, A.7
Imai, E.8
Hori, M.9
-
172
-
-
0034793893
-
Inhibitory effect of Y-27632, a ROCK inhibitor, on progression of rat liver fibrosis in association with inactivation of hepatic stellate cells
-
DOI 10.1016/S0168-8278(01)00169-6, PII S0168827801001696
-
Murata T, Arii S, Nakamura T, et al. Inhibitory effect of Y-27632, a ROCK inhibitor, on progression of rat liver fibrosis in association with inactivation of hepatic stellate cells. J Hepatol 2001; 35 (4): 474-81. (Pubitemid 32964446)
-
(2001)
Journal of Hepatology
, vol.35
, Issue.4
, pp. 474-481
-
-
Murata, T.1
Arii, S.2
Nakamura, T.3
Mori, A.4
Kaido, T.5
Furuyama, H.6
Furumoto, K.7
Nakao, T.8
Isobe, N.9
Imamura, M.10
-
173
-
-
4344704302
-
Fasudil, a Rho-kinase inhibitor, attenuates glomeruloscleros in Dahl salt-sensitive rats
-
DOI 10.1097/00004872-200409000-00024
-
Nishikimi T, Akimoto K, Wang X, et al. Fasudil, a Rhokinase inhibitor, attenuates glomerulosclerosis in Dahl salt-sensitive rats. J Hypertens 2004; 22 (9): 1787-96. (Pubitemid 39141972)
-
(2004)
Journal of Hypertension
, vol.22
, Issue.9
, pp. 1787-1796
-
-
Nishikimi, T.1
Akimoto, K.2
Wang, X.3
Mori, Y.4
Tadokoro, K.5
Ishikawa, Y.6
Shimokawa, H.7
Ono, H.8
Matsuoka, H.9
-
174
-
-
55049134780
-
Comparative gene expression profiling in three primary human cell lines after treatment with a novel inhibitor of Rho kinase or atorvastatin
-
Boerma M, Fu Q, Wang J, et al. Comparative gene expression profiling in three primary human cell lines after treatment with a novel inhibitor of Rho kinase or atorvastatin. Blood Coagul Fibrinolysis 2008; 19 (7): 709-18.
-
(2008)
Blood Coagul Fibrinolysis
, vol.19
, Issue.7
, pp. 709-718
-
-
Boerma, M.1
Fu, Q.2
Wang, J.3
-
175
-
-
0037632844
-
α-smooth muscle actin is crucial for focal adhesion maturation in myofibroblasts
-
DOI 10.1091/mbc.E02-11-0729
-
Hinz B, Dugina V, Ballestrem C, et al. Alpha-smooth muscle actin is crucial for focal adhesion maturation in myofibroblasts. Mol Biol Cell 2003; 14 (6): 2508-19. (Pubitemid 36724338)
-
(2003)
Molecular Biology of the Cell
, vol.14
, Issue.6
, pp. 2508-2519
-
-
Hinz, B.1
Dugina, V.2
Ballestrem, C.3
Wehrle-Haller, B.4
Chaponnier, C.5
-
176
-
-
0037070964
-
2-terminal peptide of α-smooth muscle actin inhibits force generation by the myofibroblast in vitro and in vivo
-
DOI 10.1083/jcb.200201049
-
Hinz B, Gabbiani G, Chaponnier C. The NH2-terminal peptide of alpha-smooth muscle actin inhibits force generation by the myofibroblast in vitro and in vivo. J Cell Biol 2002; 157 (4): 657-63. (Pubitemid 34839793)
-
(2002)
Journal of Cell Biology
, vol.157
, Issue.4
, pp. 657-663
-
-
Hinz, B.1
Gabbiani, G.2
Chaponnier, C.3
-
177
-
-
0023263236
-
Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis
-
Cantin AM, North SL, Fells GA, et al. Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis. J Clin Invest 1987; 79 (6): 1665-73. (Pubitemid 17117272)
-
(1987)
Journal of Clinical Investigation
, vol.79
, Issue.6
, pp. 1665-1673
-
-
Cantin, A.M.1
North, S.L.2
Fells, G.A.3
-
178
-
-
0024578662
-
Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis
-
Cantin AM, Hubbard RC, Crystal RG. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. AmRev Respir Dis 1989; 139 (2): 370-2. (Pubitemid 19057410)
-
(1989)
American Review of Respiratory Disease
, vol.139
, Issue.2
, pp. 370-372
-
-
Cantin, A.M.1
Hubbard, R.C.2
Crystal, R.G.3
-
179
-
-
84857119627
-
-
National Heart, Lung, and Blood Institute (NHLBI) US National Institutes of Health, Clinical Trials.gov [online] [Accessed 2011 May 25]
-
National Heart, Lung, and Blood Institute (NHLBI). Evaluating the effectiveness of prednisone, azathioprine, and N-acetylcysteine in people with idiopathic pulmonary fibrosis (PANTHER-IPF) [ClinicalTrials.gov identifier NCT00650091]. US National Institutes of Health, Clinical Trials.gov [online]. Available from URL: http://www. clinicaltrials.gov [Accessed 2011 May 25].
-
Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in People with Idiopathic Pulmonary Fibrosis (PANTHER-IPF) [ClinicalTrials.gov Identifier NCT00650091]
-
-
-
180
-
-
69949114515
-
NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury
-
Hecker L, Vittal R, Jones T, et al. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med 2009; 15 (9): 1077-81.
-
(2009)
Nat Med
, vol.15
, Issue.9
, pp. 1077-1081
-
-
Hecker, L.1
Vittal, R.2
Jones, T.3
-
181
-
-
77953054445
-
The case for personalized medicine
-
Abrahams E, Silver M. The case for personalized medicine. J Diabetes Sci Technol 2009; 3 (4): 680-4.
-
(2009)
J Diabetes Sci Technol
, vol.3
, Issue.4
, pp. 680-684
-
-
Abrahams, E.1
Silver, M.2
-
182
-
-
67349165410
-
MICA polymorphisms and decreased expression of the MICAreceptorNKG2Dcontribute to idiopathic pulmonary fibrosis susceptibility
-
Aquino-Galvez A, Perez-Rodriguez M, Camarena A, et al. MICA polymorphisms and decreased expression of the MICAreceptorNKG2Dcontribute to idiopathic pulmonary fibrosis susceptibility. Hum Genet 2009; 125 (5-6): 639-48.
-
(2009)
Hum Genet
, vol.125
, Issue.5-6
, pp. 639-648
-
-
Aquino-Galvez, A.1
Perez-Rodriguez, M.2
Camarena, A.3
-
183
-
-
57049139310
-
MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis
-
Checa M, Ruiz V, Montano M, et al. MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis. Hum Genet 2008; 124 (5): 465-72.
-
(2008)
Hum Genet
, vol.124
, Issue.5
, pp. 465-472
-
-
Checa, M.1
Ruiz, V.2
Montano, M.3
-
184
-
-
43249084804
-
MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis
-
Rosas IO, Richards TJ, Konishi K, et al. MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med 2008; 5 (4): e93.
-
(2008)
PLoS Med
, vol.5
, Issue.4
-
-
Rosas, I.O.1
Richards, T.J.2
Konishi, K.3
-
185
-
-
38049079133
-
Serumlevels of oxidative stress as a marker of disease severity in idiopathic pulmonary fibrosis
-
Daniil ZD, Papageorgiou E,KoutsokeraA, et al. Serumlevels of oxidative stress as a marker of disease severity in idiopathic pulmonary fibrosis. PulmPharmacol Ther 2008; 21 (1): 26-31.
-
(2008)
PulmPharmacol Ther
, vol.21
, Issue.1
, pp. 26-31
-
-
Daniil, Z.D.1
Papageorgiou, E.2
Koutsokera, A.3
-
186
-
-
63849228099
-
Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis
-
Kinder BW, Brown KK, McCormack FX, et al. Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis. Chest 2009; 135 (6): 1557-63.
-
(2009)
Chest
, vol.135
, Issue.6
, pp. 1557-1563
-
-
Kinder, B.W.1
Brown, K.K.2
McCormack, F.X.3
-
187
-
-
65249160219
-
Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis
-
Prasse A, Probst C, Bargagli E, et al. Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009; 179 (8): 717-23.
-
(2009)
Am J Respir Crit Care Med
, vol.179
, Issue.8
, pp. 717-723
-
-
Prasse, A.1
Probst, C.2
Bargagli, E.3
-
188
-
-
0041326688
-
1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis
-
DOI 10.1164/rccm.200210-1165OC
-
Xaubet A, Marin-Arguedas A, Lario S, et al. Transforming growth factor-beta1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003; 168 (4): 431-35 (Pubitemid 37046871)
-
(2003)
American Journal of Respiratory and Critical Care Medicine
, vol.168
, Issue.4
, pp. 431-435
-
-
Xaubet, A.1
Marin-Arguedas, A.2
Lario, S.3
Ancochea, J.4
Morell, F.5
Ruiz-Manzano, J.6
Rodriguez-Becerra, E.7
Rodriguez-Arias, J.M.8
Inigo, P.9
Sanz, S.10
Campistol, J.M.11
Mullol, J.12
Picado, C.13
|